News Events
Alan Steven Scientific Update webinar

Faster, Cleaner and Greener: Why chemistry in micellar and micellar-like media is now a viable option for chemical development

23 November 2020

CatSci are thrilled to be sponsoring a Scientific Update webinar on faster, cleaner and greener chemical development, and why chemistry in micellar and micellar-like media is now a viable option for the future.

Watch now
Ross Burn Pharma Integrates

Pharma Integrates – Partnership for Innovation: How Medicines will be Made in the Future

17 November 2020

CatSci are delighted to be participating in the ‘Partnership for innovation: how medicines will be made in future’ panel at the Pharma Integrates virtual event.

Watch now

CatSci’s continued growth recognised by win at prestigious Wales STEM Awards 2020

13 November 2020 - Cardiff, UK

CatSci, a scientifically led, commercially minded and award-winning innovation partner, has won the prestigious STEM Scale-Up of the Year award at the Wales STEM Awards 2020.

Learn more

CatSci further strengthens its customer-focused Strategic Advisory Board with three key appointments

11 November 2020 - Cardiff, UK

Cardiff, UK - CatSci, a scientifically led, commercially minded and award-winning innovation partner, has appointed three key industry thought leaders to its Strategic Advisory Board (SAB), Dr Rob Harris, Kate Smith and Dr Robert Dennehy.

Learn more
Arxspan CatSci Webinar on Electronic Lab Notebook

Webinar: Experiment. Collect Instrument Data. Analyze.

05 November 2020

Collect, process and report instrument data directly into the Integrated Analytical Module for Arxspan Electronic Lab Notebook (ELN)

Find out more

CatSci partners with three leading UK organisations to offer expert support across the pharmaceutical supply chain

21 October 2020 - Cardiff, UK

CatSci Ltd today announced partnerships with three UK companies across the pharmaceutical supply chain – M2M Pharmaceuticals (M2M Pharma), New Path Molecular (NPM) and Upperton Pharma Solutions (Upperton). This will provide CatSci’s customers with access to specialised capabilities and expertise, ensuring they can develop affordable, best-in-class small molecule therapeutics that meet their evolving healthcare needs.

Learn more